Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jabs

Showing results (291-300 of 367) with videos related to

Pageof 37
Sort By:
Ophthalmology|September 12, 2020
Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study ResultsOren Tomkins-Netzer, Susan L Lightman, Alyce E Burke, et al.
Ocular Immunology and Inflammation|April 26, 2012
The impact of macular edema on visual function in intermediate, posterior, and panuveitisSimon R J Taylor, Susan L Lightman, Elizabeth A Sugar, et al.
American Journal of Ophthalmology|June 27, 2008
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidenceJohn H Kempen, Sapna Gangaputra, Ebenezer Daniel, et al.
American Journal of Ophthalmology|July 7, 2020
Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic TherapyJohn H Kempen, Mark L Van Natta, David S Friedman, et al.
Ophthalmology|October 16, 2012
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases StudyAnthony C Gregory, John H Kempen, Ebenezer Daniel, et al.
American Journal of Ophthalmology|March 20, 2026
Imaging Measures for the Assessment of Disease Activity in Non-Infectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Taskforce: Report 10Aniruddha Agarwal, Prithvi Ramtohul, Alessandro Invernizzi, et al.
American Journal of Ophthalmology|August 19, 2008
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuityR Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
Ophthalmology|December 25, 2009
Cyclosporine for ocular inflammatory diseasesR Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
Ophthalmology|December 9, 2009
Cyclophosphamide for ocular inflammatory diseasesSiddharth S Pujari, John H Kempen, Craig W Newcomb, et al.
American Journal of Ophthalmology|August 12, 2009
Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eyeAnat Galor, Janet L Davis, Harry W Flynn, et al.
Pageof 37

Showing results (291-300 of 367) with videos related to

Sort By:
Pageof 37
Ophthalmology|September 12, 2020
Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study ResultsOren Tomkins-Netzer, Susan L Lightman, Alyce E Burke, et al.
Ocular Immunology and Inflammation|April 26, 2012
The impact of macular edema on visual function in intermediate, posterior, and panuveitisSimon R J Taylor, Susan L Lightman, Elizabeth A Sugar, et al.
American Journal of Ophthalmology|June 27, 2008
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidenceJohn H Kempen, Sapna Gangaputra, Ebenezer Daniel, et al.
American Journal of Ophthalmology|July 7, 2020
Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic TherapyJohn H Kempen, Mark L Van Natta, David S Friedman, et al.
Ophthalmology|October 16, 2012
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases StudyAnthony C Gregory, John H Kempen, Ebenezer Daniel, et al.
American Journal of Ophthalmology|March 20, 2026
Imaging Measures for the Assessment of Disease Activity in Non-Infectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Taskforce: Report 10Aniruddha Agarwal, Prithvi Ramtohul, Alessandro Invernizzi, et al.
American Journal of Ophthalmology|August 19, 2008
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuityR Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
Ophthalmology|December 25, 2009
Cyclosporine for ocular inflammatory diseasesR Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
Ophthalmology|December 9, 2009
Cyclophosphamide for ocular inflammatory diseasesSiddharth S Pujari, John H Kempen, Craig W Newcomb, et al.
American Journal of Ophthalmology|August 12, 2009
Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eyeAnat Galor, Janet L Davis, Harry W Flynn, et al.
Pageof 37